Georges Rawadi appointed CEO of StromaCare

French biotech company StromaCare has announced the appointment of Georges Rawadi as chief executive officer (CEO).
Georges’ new role will focus on raising funds and building partnerships in order to support the company’s lead product development towards clinical trials and the continued development of its pipeline.
Bringing with him over 20 years of experience in the pharma and biotech industries, Georges has held various senior positions at his prior firms. For example, he has worked as CEO and board member at Celyad Oncology and Ysopia Bioscience. He also previously worked at EureKare and Cellectis.
Ana Hennino, co-founder and chief scientific officer at StromaCare, stated: "Georges’ solid experience and track record will be a tremendous asset to our team, making him an excellent leader for StromaCare. I look forward to working with him to elevate the company's innovation, ensuring its meaningful impact on cancer treatment.”
Commenting on his appointment, Georges added: "I am very excited by the strong potential in StromaCare’s scientific and innovative approach, which will enable us to target a broad spectrum of solid cancers and overcome current treatment limitations. I am pleased to lead such a talented team and look forward to collaborating with individuals who share the same vision.”